Director, Depression Treatment Research Center
Psychiatry
Dr. John M. Zajecka, MD
|
|
Give Review
John M. Zajecka, MD is an expert in the field of Psychiatry. He went to Loyola University Chicago Stritch School of Medicine. He has 1 awards "Regional Top Doctor". John Zajecka is a published MD as well. He has 66 publications published. The latest was: Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
Publications
- The pro-inflammatory profile of depressed patients is (partly) related to obesity.
- Effect of Cognitive Therapy With Antidepressant Medications vs Antidepressants Alone on the Rate of Recovery in Major Depressive Disorder: A Randomized Clinical Trial.
- Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from...
- A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive Disorder.
- Six-year perspectives on the safety and tolerability of nefazodone.
- Antidepressant dosing and switching guidelines: focus on nefazodone.
- Symptomatic and syndromal anxiety in chronic forms of Major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combinat...
- Sexual function and satisfaction in the treatment of chronic Major depression with nefazodone, psychotherapy, and their combination.
- Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive Disorder.
- Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.
- Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
- Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
- A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive Disorder.
- The Modified Rush Sexual Inventory: preliminary psychometric findings.
- Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and p...
- Efficacy and safety of agomelatine in the treatment of major depressive Disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
- The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression.
- SNRIs in the management of acute major depressive Disorder.
- Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
- The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
- Augmentation strategies to increase antidepressant tolerability.
- Oral divalproex sodium loading for adolescent outpatients with acute mania/hypomania: a report of 2 cases.
- Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study.
- Psychosocial outcomes in patients with recurrent major depressive Disorder during 2 years of maintenance treatment with venlafaxine extended release.
- High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive Disorder: a multicenter double-blind trial.
- Calming the Bipolar storm: treating acute mania and mixed episodes in patients with Bipolar disorder.
- A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive Disorder.
- Preventing recurrent depression: long-term treatment for major depressive Disorder.
- Treating depression to remission.
- Divalproex sodium versus olanzapine in the treatment of acute mania in Bipolar disorder: health-related quality of life and medical cost outcomes.
- A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of Bipolar disorder.
- Paroxetine for prevention of Depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C.
- Susceptibility to spontaneous MAOI hypertensive episodes.
- The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
- Antidepressant combination and potentiation.
- Innovative somatic treatments for depression.
- Antidepressant drug fever.
- CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
- Coexisting major depression and obsessive-compulsive Disorder treated with venlafaxine.
- The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
- Management of comorbid anxiety and depression.
- Divalproex sodium in the treatment of refractory affective Disorders.
- The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
- Importance of establishing the diagnosis of persistent anxiety.
- Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
- Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
- Clinical management of antidepressant discontinuation.
- Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
- Mood disturbance versus other symptoms of depression in multiple sclerosis.
- Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
- Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.
- Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
- Changes in adverse events reported by patients during 6 months of fluoxetine therapy.
- Changes in weight during a 1-year trial of fluoxetine.
- Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive Disorders.
- Clinical issues in long-term treatment with antidepressants.
- A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
- Construct validity of life chart functioning scales for use in naturalistic studies of Bipolar disorder.
- Development and validation of a screening instrument for Bipolar spectrum disorder: the Mood Disorder Questionnaire.
- Pharmacotherapy of depression and mixed states in Bipolar disorder.
- Strategies for the treatment of antidepressant-related sexual dysfunction.
- Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
- Efficacy and safety of mirtazapine in major depressive Disorder patients after SSRI treatment failure: an open-label trial.
- Residual symptoms and relapse: mood, cognitive symptoms, and sleep disturbances.
Schools
Loyola Univ Of Chicago Stritch Sch Of Med
Procedures Preformed
- Family Psychotherapy
Conditions Treated
- Bipolar Disorder
- Major Depressive Disorder
- Obsessive-Compulsive Disorder (OCD)
Doctors Specialties
- Psychiatry
Accepted Insurances
- Aetna
- Cigna
- Medicare MCR
- United Healthcare
Awards
- Regional Top Doctor
Education
-
Rush University Medical Center -
Loyola University Chicago Stritch School of Medicine
Hospital
-
NorthShore Skokie Hospital -
Rush University Medical Center -
NorthShore University Health System
Helpful Reviews
Similar Doctors
|
|
Dr. Michael Ziffra, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith L. Tanner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane I. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Reff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christy A. McMillin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine D. Sterkel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashley N. Bassett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine M. Rye, DO |
|
|
Dr. Manjit L. Sandhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisette A. Cabezas, MD |
|
|
Dr. Maxwell R. Rovner, MD |
|
|
Dr. Yuri Shvartsman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sujatha K. Wolff, MD
This Doctor is OpenDoctor Recommended.
|